529 related articles for article (PubMed ID: 15695780)
21. Quantification of dopamine transporters in the mouse brain using ultra-high resolution single-photon emission tomography.
Acton PD; Choi SR; Plössl K; Kung HF
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):691-8. PubMed ID: 11976810
[TBL] [Abstract][Full Text] [Related]
22. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
[TBL] [Abstract][Full Text] [Related]
23. Absolute quantification in dopaminergic neurotransmission SPECT using a Monte Carlo-based scatter correction and fully 3-dimensional reconstruction.
Cot A; Falcón C; Crespo C; Sempau J; Pareto D; Bullich S; Lomeña F; Calviño F; Pavía J; Ros D
J Nucl Med; 2005 Sep; 46(9):1497-504. PubMed ID: 16157533
[TBL] [Abstract][Full Text] [Related]
24. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
[TBL] [Abstract][Full Text] [Related]
25. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
[TBL] [Abstract][Full Text] [Related]
26. Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.
Vriend C; Raijmakers P; Veltman DJ; van Dijk KD; van der Werf YD; Foncke EM; Smit JH; Berendse HW; van den Heuvel OA
J Neurol Neurosurg Psychiatry; 2014 Feb; 85(2):159-64. PubMed ID: 23813742
[TBL] [Abstract][Full Text] [Related]
27. Greater striatal dopamine transporter density may be associated with major depressive episode.
Amsterdam JD; Newberg AB; Soeller I; Shults J
J Affect Disord; 2012 Dec; 141(2-3):425-31. PubMed ID: 22482744
[TBL] [Abstract][Full Text] [Related]
28. Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.
Bao SY; Wu JC; Luo WF; Fang P; Liu ZL; Tang J
J Neuroimaging; 2000 Oct; 10(4):200-3. PubMed ID: 11147397
[TBL] [Abstract][Full Text] [Related]
29. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
[TBL] [Abstract][Full Text] [Related]
30. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
[TBL] [Abstract][Full Text] [Related]
31. 99mTc-M-TRODAT is not superior to (99m)Tc-TRODAT-1 for the diagnosis of Parkinson's disease.
Maes A; Vanbilloen H; Cleynhens B; Mortelmans L; Bormans G; Verbruggen A
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):796-7. PubMed ID: 12618905
[No Abstract] [Full Text] [Related]
32. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease.
Kao PF; Tzen KY; Yen TC; Lu CS; Weng YH; Wey SP; Ting G
Nucl Med Commun; 2001 Feb; 22(2):151-4. PubMed ID: 11258401
[TBL] [Abstract][Full Text] [Related]
33. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls.
Amsterdam JD; Newberg AB
Neuropsychobiology; 2007; 55(3-4):167-70. PubMed ID: 17657170
[TBL] [Abstract][Full Text] [Related]
34. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
[TBL] [Abstract][Full Text] [Related]
35. Increased dopamine transporter density in Parkinson's disease patients with Social Anxiety Disorder.
Moriyama TS; Felicio AC; Chagas MH; Tardelli VS; Ferraz HB; Tumas V; Amaro-Junior E; Andrade LA; Crippa JA; Bressan RA
J Neurol Sci; 2011 Nov; 310(1-2):53-7. PubMed ID: 21783205
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
[TBL] [Abstract][Full Text] [Related]
37. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
38. No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers.
van de Giessen E; Hesse S; Caan MW; Zientek F; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Guignard R; Akdemir UO; Knudsen GM; Nobili F; Pagani M; Vander Borght T; Van Laere K; Varrone A; Tatsch K; Booij J; Sabri O
Neuroimage; 2013 Jan; 64():61-7. PubMed ID: 22982354
[TBL] [Abstract][Full Text] [Related]
39. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
Kanyó B; Argyelán M; Dibó G; Szakonyi Z; Vécsei L; Fülöp F; Láncz A; Forgács P; Pávics L
Ideggyogy Sz; 2003 Jul; 56(7-8):231-40. PubMed ID: 12971118
[TBL] [Abstract][Full Text] [Related]
40. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
